These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24194464)

  • 1. The pharmacology of fenbufen, 3-(4-biphenylylcarbonyl)propionic acid, and 4-biphenylacetic acid, interesting antiinflammatory-analgesic agents.
    Sloboda AE; Osterberg AC
    Inflammation; 1976 Dec; 1(4):415-38. PubMed ID: 24194464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacological properties of fenbufen. A review.
    Sloboda AE; Tolman EL; Osterberg AC; Panagides J
    Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic properties of fenbufen.
    Kerwar SS
    Am J Med; 1983 Oct; 75(4B):62-9. PubMed ID: 6356910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function.
    Kohler C; Tolman E; Wooding W; Ellenbogen L
    Arzneimittelforschung; 1980; 30(4A):702-7. PubMed ID: 6254545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicology studies of fenbufen.
    Bolte HF; Koralek AV; Traitor CE
    Arzneimittelforschung; 1980; 30(4A):721-5. PubMed ID: 6159904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity.
    Nakamura H; Yokoyama Y; Motoyoshi S; Ishii K; Imazu C; Seto Y; Kadokawa T; Shimizu M
    Arzneimittelforschung; 1983; 33(11):1555-69. PubMed ID: 6607053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne. 1st communication: antiinflammatory, analgesic and other related properties.
    Tanaka K; Shimotori T; Makino S; Aikawa Y; Inaba T; Yoshida C; Takano S
    Arzneimittelforschung; 1992 Jul; 42(7):935-44. PubMed ID: 1418059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fenbufen, a new anti-inflammatory analgesic: synthesis and structure-activity relationships of analogs.
    Child RG; Osterberg AC; Sloboda AE; Tomcufcik AS
    J Pharm Sci; 1977 Apr; 66(4):466-76. PubMed ID: 300797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new non-steroidal anti-inflammatory analgesic: gamma-oxo (1,1'-biphenyl)-4-butanoic acid (fenbufen). Chemistry and activity of analogs.
    Child RG; Osterberg AC; Sloboda AE; Tomcufcik AS
    Arzneimittelforschung; 1980; 30(4A):695-702. PubMed ID: 7192122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of fenbufen in several laboratory animals.
    Chiccarelli FS; Eisner HJ; Van Lear GE
    Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive toxicology of fenbufen.
    Jackson BA; Tonelli G; Chiesa F; Alvarez L
    Arzneimittelforschung; 1980; 30(4A):725-8. PubMed ID: 7192123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study of the interaction of nonsteroidal anti-inflammatory agents--voltaren and acetylsalicylic acid--with beta-adrenoblockers].
    Siubaev RD; Shvarts GIa
    Biull Eksp Biol Med; 1984 Jul; 98(7):48-51. PubMed ID: 6147164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal antiinflammatory agents-part 2 antiinflammatory, analgesic and antipyretic activity of some substituted 3-pyrazolin-5-ones and 1,2,4,5,6,7-3H-hexahydroindazol-3-ones.
    El-Hawash SA; Badawey el-SA; El-Ashmawey IM
    Eur J Med Chem; 2006 Feb; 41(2):155-65. PubMed ID: 16375992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic profile of a new compound with antiinflammatory activity: 2-(4-dimethylvinylphenyl)propionic acid (Gx 258)].
    Bossoni G; Coppi G; Lumachi B; Milanino R; Passarella E; Toson G; Valsecchi B
    Farmaco Sci; 1984 May; 39(5):421-9. PubMed ID: 6610567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites.
    Akahane K; Kimura Y; Tsutomi Y; Hayakawa I
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2323-9. PubMed ID: 7840564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier-linked mutual prodrugs of biphenylacetic acid as a promising alternative to bioprecursor fenbufen: design, kinetics, and pharmacological studies.
    Dhaneshwar S; Kusurkar M; Bodhankar S; Bihani G
    Inflammopharmacology; 2014 Aug; 22(4):235-50. PubMed ID: 24178955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (1). Effect on the central nervous system].
    Furuhata K; Hiraiwa T; Ono S; Tanaka K; Shimotori T; Makino S; Kitamura K; Aikawa Y; Izumi Y; Kimura T
    Jpn J Antibiot; 1995 May; 48(5):692-705. PubMed ID: 7637204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
    Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
    Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds.
    Ito Y; Miyasaka T; Fukuda H; Akahane K; Kimura Y
    Neuropharmacology; 1996; 35(9-10):1263-9. PubMed ID: 9014141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adverse drug interactions between pyridonecarboxylic acids and nonsteroidal antiinflammatory drugs: convulsion after oral or intracerebral administration in mice].
    Hirai S; Tanaka K; Makino S; Narita H
    Yakugaku Zasshi; 1989 Feb; 109(2):119-26. PubMed ID: 2746470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.